The RECIST criteria: Implications for diagnostic radiologists

British Journal of Radiology

Volumn 74, Issue 887, 2001, Pages 983-986

  Padhani, A R ^a   Ollivier, L ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

CANCER; CANCER REGRESSION; CANCER SIZE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG RESPONSE; GOOD CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT MONITORING; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; PROSPECTIVE STUDY; RADIOLOGIST; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; IMAGE QUALITY; NEOPLASM; RADIOGRAPHY;

ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; RADIOGRAPHIC IMAGE ENHANCEMENT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0035202667     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.74.887.740983     Document Type: Note

References (10)

1. Reporting results of cancer treatment
2. New guidelines to evaluate the response to treatment in solid tumors
3. Measuring response in solid tumors: Unidimensional versus bidimensional measurement
4. Measure once or twice - Does it really matter?
5. Are current tumour response criteria relevant for the 21st century?
6. Imaging of treated cancer
7. Studies in variation associated with the measurement of solid tumors
8. Response rate accuracy in oncology trials: Reasons for interobserver variability